MANAGEMENT OF ENDOCRINE DISEASE: A clinical update on tumor-induced hypoglycemia
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Tumor-induced hypoglycemia (TIH) is a rare clinical entity that may occur in patients with diverse kinds of tumor lineages and that may be caused by different mechanisms. These pathogenic mechanisms include the eutopic insulin secretion by a pancreatic islet β-cell tumor, and also the ectopic tumor insulin secretion by non-islet-cell tumor, such as bronchial carcinoids and gastrointestinal stromal tumors. Insulinoma is, by far, the most common tumor associated with clinical and biochemical hypoglycemia. Insulinomas are usually single, small, sporadic, and intrapancreatic benign tumors. Only 5–10% of insulinomas are malignant. Insulinoma may be associated with the multiple endocrine neoplasia type 1 in 4–6% of patients. Medical therapy with diazoxide or somatostatin analogs has been used to control hypoglycemic symptoms in patients with insulinoma, but only surgical excision by enucleation or partial pancreatectomy is curative. Other mechanisms that may, more uncommonly, account for tumor-associated hypoglycemia without excess insulin secretion are the tumor secretion of peptides capable of causing glucose consumption by different mechanisms. These are the cases of tumors producing IGF2 precursors, IGF1, somatostatin, and glucagon-like peptide 1. Tumor autoimmune hypoglycemia occurs due to the production of insulin by tumor cells or insulin receptor autoantibodies. Lastly, massive tumor burden with glucose consumption, massive tumor liver infiltration, and pituitary or adrenal glands destruction by tumor are other mechanisms for TIH in cases of large and aggressive neoplasias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study.
SERVICE, F. J., McMAHON, M. M., O'BRIEN, P. C., & BALLARD, D. J. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62083-7 · Cited by 883
Service, F. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504273321707 · Cited by 503
Placzkowski, K. A., Vella, A., Thompson, G. B., Grant, C. S., Reading, C. C., Charboneau, J. W., Andrews, J. C., Lloyd, R. V., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2031 · Cited by 360
Non-Islet Cell Tumour-Induced Hypoglycaemia: A Review of the Literature Including Two New Cases
de Groot, J. W. B., Rikhof, B., van Doorn, J., Bilo, H. J. G., Alleman, M. A., Honkoop, A. H., & van der Graaf, W. T. A. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0161 · Cited by 222
Imaging and localization of islet-cell tumours of the pancreas on CT and MRI.
Noone, T. C., Hosey, J., Firat, Z., & Semelka, R. C. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.013 · Cited by 217
Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia.
Fukuda, I., Hizuka, N., Ishikawa, Y., Yasumoto, K., Murakami, Y., Sata, A., Morita, J., Kurimoto, M., Okubo, Y., & Takano, K. (2006) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2006.05.003 · Cited by 186 · cited 1×
“IGF2, Fukuda et al. (2006) (69) found that hypoglycemic”
Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix.
Seckl, M. J., Mulholland, P. J., Bishop, A. E., Teale, J. D., Hales, C. N., Glaser, M., Watkins, S., & Seckl, J. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411004 · Cited by 75
Insulin autoimmunity and hypoglycemia in seven white patients.
Basu, A., Service, F. J., Yu, L., Heser, D., Ferries, L. M., & Eisenbarth, G. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.97 · Cited by 66
Nauck, M. A., Reinecke, M., Perren, A., Frystyk, J., Berishvili, G., Zwimpfer, C., Figge, A. M., Flyvbjerg, A., Lankisch, P. G., Blum, W. F., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2573 · Cited by 63
Hypoglycemia due to an insulin binding antibody in a patient with an IgA-κ myeloma.
Halsall, D. J., Mangi, M., Soos, M., Fahie-Wilson, M. N., Wark, G., Mainwaring-Burton, R., & O’Rahilly, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0075 · Cited by 56
Miraki-Moud, F., Grossman, A. B., Besser, M., Monson, J. P., & Camacho-Hübner, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2090 · Cited by 44
Ishikura, K., Takamura, T., Takeshita, Y., Nakagawa, A., Imaizumi, N., Misu, H., Taji, K., Kasahara, K., Oshinoya, Y., Suzuki, S., et al. (2010) · BMJ Case Reports · doi:10.1136/bcr.07.2009.2100 · Cited by 20
Recurrent hyperinsulinemic hypoglycemia caused by an insulin-secreting insulinoma.
Service, F. J. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0263 · Cited by 19
Cited by
MANAGEMENT OF ENDOCRINE DISEASE: Pathogenesis and management of hypoglycemia
Kittah, N. E., & Vella, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1062 · Cited by 107
Schovanek, J., Cibickova, L., Ctvrtlik, F., Tudos, Z., Karasek, D., Iacobone, M., & Frysak, Z. (2019) · Journal of Cancer · doi:10.7150/jca.30472 · Cited by 16
“The first-line and only curative option for insulinoma is surgical excision by enucleation or partial pancreatectomy [3].”
BackgroundReceptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
Boss, M., Bos, D., Frielink, C., Sandker, G., Bronkhorst, P., van Lith, S. A. M., Brom, M., Buitinga, M., & Gotthardt, M. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.238998 · Cited by 15
Non-glycosylated IGF2 prohormones are more mitogenic than native IGF2
(2023) · doi:10.1038/s42003-023-05239-6 · Cited by 12
Alkaissi, H. R., Mostel, Z., & McFarlane, S. I. (2022) · Cureus · doi:10.7759/cureus.25813 · Cited by 7
“DOI 10.7759/cureus.25813 5 of 8 suppressed insulin, proinsulin, and C-peptide with no response to diazoxide treatment, ruling out insulin and GLP-1 mediated etiologies.”
BackgroundInfluential
Metadata
- Authors
- Iglesias, P., & Díez, J. J.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04
- Volume
- 170
- Issue
- 4
- Pages
- R147-R157
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2120766385
- Cited by
- 158
- References
- 14
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.